Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07239661
What this trial is testing

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerElectroacupuncturePD-1 Inhibitors+1 more
Kong Fanming 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Not applicableUnknownNCT04193956
What this trial is testing

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

Who this might be right for
MelanomaNon-Small Cell Lung Cancer
University Medical Center Groningen 3,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT04808999
What this trial is testing

Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)

Who this might be right for
Squamous Cell Carcinoma
Diwakar Davar 30
Testing effectiveness (Phase 2)Looking for participantsNCT07504471
What this trial is testing

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07740941
What this trial is testing

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage Stage IIIBMelanoma Stage M1+1 more
UNC Lineberger Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT06121505
What this trial is testing

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Who this might be right for
Lung Squamous Cell Carcinoma
Sichuan University 114
Not applicableStudy completedNCT06991907
What this trial is testing

PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety

Who this might be right for
HCC - Hepatocellular Carcinoma125I Seeds Implantation
Jiangxi Provincial Cancer Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05632939
What this trial is testing

ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.

Who this might be right for
Gastric CancerGastroesophageal Cancer (GC)
AskGene Pharma, Inc. 62
Testing effectiveness (Phase 2)UnknownNCT05913661
What this trial is testing

Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaDigestive System Neoplasms+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466303
What this trial is testing

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Who this might be right for
Breast CancerSerplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
Xijing Hospital 84
Post-approval studies (Phase 4)Looking for participantsNCT06457503
What this trial is testing

Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc. 100
Testing effectiveness (Phase 2)UnknownNCT05878028
What this trial is testing

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

Who this might be right for
Non-small Cell Lung Cancer
Quanli Gao 33
Testing effectiveness (Phase 2)Study completedNCT04518280
What this trial is testing

Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fudan University 130
Not applicableUnknownNCT05420922
What this trial is testing

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Who this might be right for
Hepatocellular CarcinomaProgrammed Cell Death 1Effects of Immunotherapy
Tongji Hospital 2,000
Not applicableStudy completedNCT02153151
What this trial is testing

Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 21
Testing effectiveness (Phase 2)UnknownNCT05460481
What this trial is testing

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
Hunan Cancer Hospital 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297030
What this trial is testing

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 37
Testing effectiveness (Phase 2)Study completedNCT03308942
What this trial is testing

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

Who this might be right for
Neoplasms
Tesaro, Inc. 53
Next Page